Keytruda: All about the immunotherapy drug that is being used to treat different types of cancers

Keytruda's first approval by US FDA came in the year 2014 for advanced skin cancer. Now, the immunotherapy drug is being used ...

Oncologists explain why they prescribe Keytruda to cancer patients, when and how it works

Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it ...

How Keytruda is changing cancer treatment in India? Noida-based cancer specialist explains

Keytruda, an immunotherapy drug, is transforming cancer treatment in India by helping the immune system fight cancer cells.

Merck's Keytruda: A lifesaving drug, a global divide

A cross-border investigation by DW and ICIJ reveals how pricing and patents helped turn a life-saving medicine into one of ...
Seeking Alpha

KEYTRUDA® (pembrolizumab) Demonstrates Long-Term Survival Benefit in Certain Patients With Earlier or Advanced Stages of Non-Small Cell Lung Cancer (NSCLC)

Five-year exploratory follow-up analysis of KEYNOTE-671 continued to show clinically meaningful improvements in overall survival and event-free survival with KEYTRUDA plus chemotherapy before surgery, ...
International Consortium of Investigative Journalists

Frequently asked questions about the Cancer Calculus investigation

Some of the philanthropic foundations that fund ICIJ have programs or campaigns advocating for reform of the pharmaceutical ...